Black Soldier Fly Market (2026-2036)

The growth of this market is mainly driven by demand for alternative proteins in aquafeed and pet food and regulatory authorization across major feed markets in the EU, the U.S., and Canada. However, the cost gap against fishmeal and soybean meal and substrate restrictions limiting access to low-cost feedstock restrain the growth of this market.

Furthermore, functional positioning in aquafeed and premium pet food and chitin and chitosan recovery for high-value applications are expected to offer growth opportunities for the stakeholders in this market. However, restoring investor confidence after sector insolvencies and demonstrating utilization at commercial scale remain major challenges impacting the growth of this market. Additionally, multi-product revenue models and phased capacity building and technology licensing are prominent trends in this market.

The Black Soldier Fly Market comprises products derived from the commercial rearing of the black soldier fly (Hermetia illucens), a non-pest species that converts organic side streams into protein, lipid, and fertilizer products. Larvae are grown on vegetable-origin substrates over a cycle of about two weeks and are harvested before pupation and processed into defatted protein meal, whole larvae sold live, frozen, or dried, extracted larvae oil, biofertiliser (frass) made from residual rearing substrate, and chitin and chitosan recovered from the exoskeleton. The species accounts for most industrial insect production worldwide because it converts a wide range of permitted substrates efficiently, completes its larval cycle quickly, and has an adult stage that does not feed and carries no disease. Market value is measured at producer selling price and is reported in both value and volume terms. The market excludes insects of other species, larvae reared for on-farm use without commercial sale, equipment and technology supplied to producers, biological inputs traded between producers, and organic waste management services where no insect-derived product is sold.

Commercial black soldier fly production is barely fifteen years old and has developed in three phases. The first phase, from roughly 2009 to 2016, was marked by pilot facilities and proof-of-concept work, with Protix founded in the Netherlands in 2009 and opening its first pilot facility in 2015. The second phase, from roughly 2017 to 2023, was defined by capital rather than production, with investors committing about USD 1.65 billion to insect farming according to AgFunder, and black soldier fly ventures taking the largest share. Innovafeed completed a USD 250 million Series D with participation from ADM, Cargill, and the Qatar Investment Authority, Protix opened a 14,000 square meter facility at Bergen op Zoom in 2019 and formed a joint venture with Bühler in 2017 to supply rearing and processing systems, and Entobel raised USD 33.3 million to commission a Vietnamese facility able to produce 10,000 tons of protein meal a year.

Regulation has shaped this market more directly than any commercial factor. Regulation (EU) 2017/893 permitted insect processed animal proteins in EU aquaculture feed, and Regulation (EU) 2021/1372 extended authorization to poultry and pig feed across seven species, including the black soldier fly. In the United States, dried black soldier fly larvae are the only insect product to have completed the AAFCO ingredient definition process, covering finfish, poultry, and swine feed and adult dog and cat food, while in Canada the CFIA approved black soldier fly products for broilers in 2016, aquaculture in 2017, and all poultry in 2018. In the EU, frass placed on the market as a fertilizing product must be heat-treated, providing a regulatory basis for selling it as a defined agricultural input.

The third phase began from 2024 when facilities failed to perform as projected. Innovafeed's 2024 accounts show revenue of EUR 5.11 million against total assets of EUR 240.37 million, and in June 2026 the company reorganized around its Nesle site with a EUR 51 million round from existing investors; its Decatur pilot in Illinois was placed on standby. Protix confirmed in February 2025 that its planned Polish plant was on hold, and the European Investment Bank has stated that its loan of up to EUR 37 million was cancelled without disbursement. The industry entering the forecast period is smaller and more cautious but not uniformly weaker: nextProtein raised EUR 18 million in November 2025 and a further USD 11.2 million in August 2026, and a distinct biological inputs layer has emerged, with Beta Bugs and FreezeM agreeing in August 2026 to establish a HiPer-Fly breeding population in Germany, allowing producers to buy standardized eggs or neonates instead of maintaining their own colonies.